Technical Analysis for SBIO - ALPS Medical Breakthroughs ETF
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
35.73 | -0.67% | -0.24 |
SBIO closed down 0.67 percent on Friday, September 13, 2019, on 49 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| See historical SBIO trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Slingshot Bullish | Bullish Swing Setup | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Upper Bollinger Band Walk | Strength | -0.67% | |
| Overbought Stochastic | Strength | -0.67% | |
| Upper Bollinger Band Touch | Strength | -0.67% | |
| MACD Bullish Centerline Cross | Bullish | -2.43% | |
| Pocket Pivot | Bullish Swing Setup | -2.43% | |
| Stochastic Reached Overbought | Strength | -2.43% | |
| Above Upper BB | Strength | -2.43% |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM.
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.
Index Fund Biotechnology Pharmaceutical Passive Management
Index Fund Biotechnology Pharmaceutical Passive Management
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more SBIO news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 39.61 |
| 52 Week Low | 25.49 |
| Average Volume | 27,090 |
| 200-Day Moving Average | 33.9095 |
| 50-Day Moving Average | 35.1975 |
| 20-Day Moving Average | 34.8967 |
| 10-Day Moving Average | 34.918 |
| Average True Range | 0.8398 |
| ADX | 15.7 |
| +DI | 26.8526 |
| -DI | 16.082 |
| Chandelier Exit (Long, 3 ATRs ) | 34.2006 |
| Chandelier Exit (Short, 3 ATRs ) | 35.9594 |
| Upper Bollinger Band | 36.6753 |
| Lower Bollinger Band | 33.1181 |
| Percent B (%b) | 0.73 |
| BandWidth | 10.193514 |
| MACD Line | 0.1675 |
| MACD Signal Line | -0.0553 |
| MACD Histogram | 0.2228 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 36.40 | ||||
| Resistance 3 (R3) | 36.47 | 36.32 | 36.29 | ||
| Resistance 2 (R2) | 36.32 | 36.15 | 36.29 | 36.25 | |
| Resistance 1 (R1) | 36.03 | 36.05 | 35.95 | 35.95 | 36.21 |
| Pivot Point | 35.88 | 35.88 | 35.84 | 35.84 | 35.88 |
| Support 1 (S1) | 35.58 | 35.71 | 35.51 | 35.51 | 35.25 |
| Support 2 (S2) | 35.43 | 35.60 | 35.40 | 35.21 | |
| Support 3 (S3) | 35.14 | 35.43 | 35.17 | ||
| Support 4 (S4) | 35.06 |
